Editorial Commentary: Viva No Difference!
نویسندگان
چکیده
منابع مشابه
Editorial Commentary Have No Fear , MitoQ 10 Is Here
The physical manifestation of a trait is a constant interplay between one’s genetic makeup and environmental factors. This notion has been substantiated by nutrigenomic studies demonstrating the benefits of nutritional supplements along the continuum between health and disease.1 More importantly, these studies have revealed the plasticity by which the genetic substrate can interact with various...
متن کاملEditorial Commentary
Socioeconomic status (SES) is a known risk factor for cardiovascular disease.1,2 However, unlike traditional Framingham risk factors, SES does not directly impact the cardiovascular system but exerts its cardiovascular effects via a complex interaction of biobehavioral factors, such as exercise and diet (Figure). Because these mediating behavioral factors are potentially modifiable, elucidating...
متن کاملThe question what of subject-based commentary and its difference with Quran to Quran commentary
Subject-based commentary is one of the methods more used by commentators in recent decades than before. In this method, commentators may take a Quranic subject on the basis of inter-Quranic or metaphysical fields, or on the grounds of individual and social life. This method differs from that of Quran to Quran. The latter would lead to explanation and deep perception of the meaning of Quranic wo...
متن کاملEditorial: review and commentary section.
Is this the era of empirically supported practice? If it is not, it is up to us to make it so. Many of us were trained in the scientist–practitioner framework of the Boulder model, now almost 60 years old, which emphasized training in both research and practice for clinical psychologists, and which seems to make the implicit assumption that the ‘‘science’’ training would help to make the ‘‘prac...
متن کاملEditorial Commentary Protein Kinase C–Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference
The inhibition of the renin-angiotensin axis with the angiotensin II (ATII) receptor blockers, such as losartan, candesartan, and valsartan, has been demonstrated, similar to angiotensin-converting enzyme inhibitors, to reduce mortality in patients with arterial hypertension, chronic congestive heart failure, and acute myocardial infarction.1 Initially, the ATII receptor antagonist losartan hel...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2012
ISSN: 1058-4838,1537-6591
DOI: 10.1093/cid/cis656